{"id":13022,"date":"2023-07-24T22:52:56","date_gmt":"2023-07-24T20:52:56","guid":{"rendered":"https:\/\/tirzepatyd.eu\/?post_type=product&#038;p=13022"},"modified":"2026-04-18T11:31:02","modified_gmt":"2026-04-18T09:31:02","slug":"tirzepatid-pen-5-mg","status":"publish","type":"product","link":"https:\/\/tirzepatyd.eu\/en\/shop-product\/tirzepatid-pen-5-mg\/","title":{"rendered":"GLP1+GIP PEN 5 mg"},"content":{"rendered":"\t\t<div data-elementor-type=\"product-post\" data-elementor-id=\"13022\" class=\"elementor elementor-13022\" data-elementor-post-type=\"product\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-1c9a362 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1c9a362\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-e55e78a\" data-id=\"e55e78a\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-de7ceca elementor-widget__width-initial elementor-widget elementor-widget-text-editor\" data-id=\"de7ceca\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<article class=\"text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [&amp;:has([data-writing-block])&gt;*]:pointer-events-auto scroll-mt-(--header-height)\" dir=\"auto\" tabindex=\"-1\" data-turn-id=\"e3ed3882-f8db-476f-b63a-f3b595823a65\" data-testid=\"conversation-turn-1\" data-scroll-anchor=\"false\" data-turn=\"user\"><\/article><article class=\"text-token-text-primary w-full focus:outline-none [--shadow-height:45px] has-data-writing-block:pointer-events-none has-data-writing-block:-mt-(--shadow-height) has-data-writing-block:pt-(--shadow-height) [&amp;:has([data-writing-block])&gt;*]:pointer-events-auto scroll-mt-[calc(var(--header-height)+min(200px,max(70px,20svh)))]\" dir=\"auto\" tabindex=\"-1\" data-turn-id=\"efd72c8c-cd4b-43c4-a977-956c8e7c8200\" data-testid=\"conversation-turn-2\" data-scroll-anchor=\"false\" data-turn=\"assistant\"><div class=\"text-base my-auto mx-auto [--thread-content-margin:--spacing(4)] @w-sm\/main:[--thread-content-margin:--spacing(6)] @w-lg\/main:[--thread-content-margin:--spacing(16)] px-(--thread-content-margin)\"><div class=\"[--thread-content-max-width:40rem] @w-lg\/main:[--thread-content-max-width:48rem] mx-auto max-w-(--thread-content-max-width) flex-1 group\/turn-messages focus-visible:outline-hidden relative flex w-full min-w-0 flex-col agent-turn\" tabindex=\"-1\"><div class=\"flex max-w-full flex-col grow\"><div class=\"min-h-8 text-message relative flex w-full flex-col items-end gap-2 text-start break-words whitespace-normal [.text-message+&amp;]:mt-1\" dir=\"auto\" data-message-author-role=\"assistant\" data-message-id=\"34214bcf-bc3f-438d-b257-a00513477b14\" data-message-model-slug=\"gpt-5-2\"><div class=\"flex w-full flex-col gap-1 empty:hidden first:pt-[1px]\"><div class=\"markdown prose dark:prose-invert w-full wrap-break-word light markdown-new-styling\"><h2 data-start=\"0\" data-end=\"97\">Tirzepatid pen 5 mg \u2013 charakterystyka podw\u00f3jnego agonisty GIP\/GLP-1<\/h2><p data-start=\"351\" data-end=\"711\">Termin <strong data-start=\"358\" data-end=\"376\">tirzepatid pen<\/strong> odnosi si\u0119 do postaci podania stosowanej w badaniach klinicznych nad syntetycznym analogiem peptydowym o aktywno\u015bci wobec receptor\u00f3w GIPR oraz GLP-1R. W dokumentacji bada\u0144 fazy III okre\u015blenie to odnosi si\u0119 do gotowej postaci dawkowania umo\u017cliwiaj\u0105cej podanie podsk\u00f3rne raz w tygodniu w warunkach kontrolowanych protoko\u0142\u00f3w klinicznych.<\/p><p data-start=\"713\" data-end=\"923\">W kontek\u015bcie laboratoryjnym okre\u015blenie <em data-start=\"752\" data-end=\"768\">tirzepatid pen<\/em> mo\u017ce funkcjonowa\u0107 jako model referencyjny dla bada\u0144 nad farmakokinetyk\u0105 podania podsk\u00f3rnego oraz ocen\u0105 zale\u017cno\u015bci dawka\u2013efekt dla agonist\u00f3w inkretynowych.<\/p><hr data-start=\"925\" data-end=\"928\" \/><h2 data-start=\"930\" data-end=\"978\">Mechanizm dzia\u0142ania Tirzepatid pen w modelach receptorowych<\/h2><p data-start=\"980\" data-end=\"1136\"><span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Tirzepatide<\/span><\/span>\u00a0jest podw\u00f3jnym agonist\u0105 receptor\u00f3w GIP oraz GLP-1, nale\u017c\u0105cych do rodziny receptor\u00f3w sprz\u0119\u017conych z bia\u0142kiem G (GPCR).<\/p><p data-start=\"1138\" data-end=\"1173\">W badaniach molekularnych wykazano:<\/p><ul data-start=\"1175\" data-end=\"1421\"><li data-start=\"1175\" data-end=\"1222\"><p data-start=\"1177\" data-end=\"1222\">aktywacj\u0119 szlaku cAMP w kom\u00f3rkach \u03b2 trzustki,<\/p><\/li><li data-start=\"1223\" data-end=\"1269\"><p data-start=\"1225\" data-end=\"1269\">nasilenie glukozozale\u017cnej sekrecji insuliny,<\/p><\/li><li data-start=\"1270\" data-end=\"1329\"><p data-start=\"1272\" data-end=\"1329\">supresj\u0119 wydzielania glukagonu w warunkach hiperglikemii,<\/p><\/li><li data-start=\"1330\" data-end=\"1365\"><p data-start=\"1332\" data-end=\"1365\">wp\u0142yw na sygnalizacj\u0119 \u03b2-arrestyn,<\/p><\/li><li data-start=\"1366\" data-end=\"1421\"><p data-start=\"1368\" data-end=\"1421\">modulacj\u0119 centralnych szlak\u00f3w reguluj\u0105cych \u0142aknienie.<\/p><\/li><\/ul><p data-start=\"1423\" data-end=\"1608\">Mechanizm podw\u00f3jnego agonizmu GIP\/GLP-1 opisano szczeg\u00f3\u0142owo w analizie Min T. i wsp. (2023, PMC10107501), wskazuj\u0105c na mo\u017cliwy efekt synergistyczny w regulacji homeostazy energetycznej.<\/p><hr data-start=\"1610\" data-end=\"1613\" \/><h2 data-start=\"1615\" data-end=\"1678\">Dane kliniczne z bada\u0144 nad tirzepatide<\/h2><p data-start=\"1680\" data-end=\"1814\">W badaniu <strong data-start=\"1690\" data-end=\"1704\">SURMOUNT-1<\/strong> (NEJM 2022; PubMed 35658024) analizowano dawki 5 mg, 10 mg i 15 mg podawane raz w tygodniu przez 72 tygodnie.<\/p><p data-start=\"1816\" data-end=\"1885\">Dla dawki odpowiadaj\u0105cej postaci <strong data-start=\"1849\" data-end=\"1872\">tirzepatid pen 5 mg<\/strong> raportowano:<\/p><ul data-start=\"1887\" data-end=\"2075\"><li data-start=\"1887\" data-end=\"1951\"><p data-start=\"1889\" data-end=\"1951\">\u015bredni\u0105 redukcj\u0119 masy cia\u0142a ~15% wzgl\u0119dem warto\u015bci wyj\u015bciowej,<\/p><\/li><li data-start=\"1952\" data-end=\"1996\"><p data-start=\"1954\" data-end=\"1996\">istotn\u0105 popraw\u0119 parametr\u00f3w metabolicznych,<\/p><\/li><li data-start=\"1997\" data-end=\"2037\"><p data-start=\"1999\" data-end=\"2037\">redukcj\u0119 obwodu talii i trigliceryd\u00f3w,<\/p><\/li><li data-start=\"2038\" data-end=\"2075\"><p data-start=\"2040\" data-end=\"2075\">popraw\u0119 marker\u00f3w insulinooporno\u015bci.<\/p><\/li><\/ul><p data-start=\"2077\" data-end=\"2263\">W programie <strong data-start=\"2089\" data-end=\"2102\">SURPASS-2<\/strong> (NEJM 2021) wykazano istotne obni\u017cenie HbA1c oraz wi\u0119ksz\u0105 redukcj\u0119 masy cia\u0142a w por\u00f3wnaniu z selektywnym agonist\u0105 GLP-1 \u2013 <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Semaglutide<\/span><\/span>.<\/p><hr data-start=\"2265\" data-end=\"2268\" \/><h2 data-start=\"187\" data-end=\"258\">Dost\u0119pno\u015b\u0107 online i gdzie mo\u017cna kupic tirzepatid pen<\/h2><p data-start=\"260\" data-end=\"593\">W kontek\u015bcie bada\u0144 klinicznych okre\u015blenie <strong data-start=\"302\" data-end=\"320\">tirzepatid pen<\/strong> odnosi si\u0119 do postaci dawkowania stosowanej w programach takich jak SURPASS i SURMOUNT. W obrocie regulowanym cz\u0105steczka <span class=\"hover:entity-accent entity-underline inline cursor-pointer align-baseline\"><span class=\"whitespace-normal\">Tirzepatide<\/span><\/span> jest zwi\u0105zkiem opracowanym do zastosowa\u0144 terapeutycznych i podlega przepisom w\u0142a\u015bciwym dla produkt\u00f3w leczniczych.<\/p><p data-start=\"595\" data-end=\"766\">W \u015brodowisku laboratoryjnym analogi lub materia\u0142y referencyjne oparte na tej cz\u0105steczce mog\u0105 by\u0107 oferowane przez wyspecjalizowanych dostawc\u00f3w odczynnik\u00f3w badawczych, jako:<\/p><ul><li data-start=\"770\" data-end=\"822\">substancje do bada\u0144 nad receptorami GIPR i GLP-1R,<\/li><li data-start=\"825\" data-end=\"889\">materia\u0142y do analiz farmakodynamicznych i farmakokinetycznych,<\/li><li data-start=\"892\" data-end=\"944\">wzorce analityczne do bada\u0144 nad sygnalizacj\u0105 GPCR,<\/li><li data-start=\"947\" data-end=\"1011\">odczynniki do projekt\u00f3w z zakresu metabolizmu glukozy i energii.<\/li><\/ul><p data-start=\"1013\" data-end=\"1227\">Dost\u0119pno\u015b\u0107 online dotyczy wy\u0142\u0105cznie podmiot\u00f3w prowadz\u0105cych obr\u00f3t odczynnikami chemicznymi lub materia\u0142ami referencyjnymi przeznaczonymi do zastosowa\u0144 badawczych. W takich przypadkach dokumentacja powinna obejmowa\u0107:<\/p><ul><li data-start=\"1231\" data-end=\"1272\">specyfikacj\u0119 czysto\u015bci (np. HPLC\/UPLC),<\/li><li data-start=\"1275\" data-end=\"1302\">certyfikat analizy (CoA),<\/li><li data-start=\"1305\" data-end=\"1344\">warunki przechowywania i stabilno\u015bci,<\/li><li data-start=\"1347\" data-end=\"1384\">oznaczenie Research Use Only (RUO),<\/li><li data-start=\"1387\" data-end=\"1415\">dane identyfikacyjne partii.<\/li><\/ul><hr data-start=\"2818\" data-end=\"2821\" \/><h2 data-start=\"2270\" data-end=\"2304\">Schemat dawkowania w badaniach<\/h2><p data-start=\"2306\" data-end=\"2362\">W protoko\u0142ach klinicznych stosowano schemat eskalacyjny:<\/p><ul data-start=\"2364\" data-end=\"2454\"><li data-start=\"2364\" data-end=\"2388\"><p data-start=\"2366\" data-end=\"2388\">2,5 mg (wprowadzenie),<\/p><\/li><li data-start=\"2389\" data-end=\"2406\"><p data-start=\"2391\" data-end=\"2406\">nast\u0119pnie 5 mg,<\/p><\/li><li data-start=\"2407\" data-end=\"2454\"><p data-start=\"2409\" data-end=\"2454\">z mo\u017cliwo\u015bci\u0105 zwi\u0119kszenia do 10 mg lub 15 mg.<\/p><\/li><\/ul><p data-start=\"2456\" data-end=\"2603\">Dawka 5 mg, odpowiadaj\u0105ca wariantowi <em data-start=\"2493\" data-end=\"2514\">tirzepatid pen 5 mg<\/em>, stanowi\u0142a istotny punkt odniesienia w analizach zale\u017cno\u015bci dawka\u2013efekt oraz tolerancji.<\/p><hr data-start=\"2605\" data-end=\"2608\" \/><h3 data-start=\"2610\" data-end=\"2632\">Znaczenie badawcze<\/h3><p data-start=\"2634\" data-end=\"2722\">W obrocie laboratoryjnym tirzepatyd funkcjonuje jako materia\u0142 referencyjny do bada\u0144 nad:<\/p><ul data-start=\"2724\" data-end=\"2855\"><li data-start=\"2724\" data-end=\"2764\"><p data-start=\"2726\" data-end=\"2764\">farmakologi\u0105 receptor\u00f3w inkretynowych,<\/p><\/li><li data-start=\"2765\" data-end=\"2785\"><p data-start=\"2767\" data-end=\"2785\">sygnalizacj\u0105 GPCR,<\/p><\/li><li data-start=\"2786\" data-end=\"2821\"><p data-start=\"2788\" data-end=\"2821\">regulacj\u0105 bilansu energetycznego,<\/p><\/li><li data-start=\"2822\" data-end=\"2855\"><p data-start=\"2824\" data-end=\"2855\">metabolizmem glukozy i lipid\u00f3w.<\/p><\/li><\/ul><p data-start=\"2857\" data-end=\"2930\">Preparat przeznaczony wy\u0142\u0105cznie do zastosowa\u0144 badawczych i analitycznych.<\/p><\/div><\/div><\/div><\/div><\/div><\/div><\/article><p data-start=\"2853\" data-end=\"2927\"><a href=\"https:\/\/tirzepatyd.eu\/de\/shop-produkt\/orforglipron\/\">Zobacz r\u00f3wnie\u017c Orforglipron 60caps\/5mg<\/a><\/p><hr data-start=\"2818\" data-end=\"2821\" \/><p data-start=\"2843\" data-end=\"3222\"><a href=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/09\/5mg-PEN-Camera.png\"><img fetchpriority=\"high\" decoding=\"async\" class=\"size-medium wp-image-30657 aligncenter\" src=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/09\/5mg-PEN-Camera-300x225.png\" alt=\"Tirzepatid pen 5mg buy online\" width=\"300\" height=\"225\" srcset=\"https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/09\/5mg-PEN-Camera-300x225.png 300w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/09\/5mg-PEN-Camera-800x600.png 800w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/09\/5mg-PEN-Camera-64x48.png 64w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/09\/5mg-PEN-Camera-768x576.png 768w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/09\/5mg-PEN-Camera-16x12.png 16w, https:\/\/tirzepatyd.eu\/wp-content\/uploads\/2025\/09\/5mg-PEN-Camera.png 1024w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/a><\/p><p data-start=\"2934\" data-end=\"2951\">\u0179r\u00f3d\u0142a naukowe:<\/p><ol data-start=\"2953\" data-end=\"4075\"><li data-start=\"2953\" data-end=\"3169\"><p data-start=\"2956\" data-end=\"3169\"><strong data-start=\"2956\" data-end=\"3020\">Min T. et al., Mechanisms of dual GIP\/GLP-1 receptor agonism<\/strong> \u2013 opis mechanizmu podw\u00f3jnego agonizmu i dzia\u0142ania biologicznego receptor\u00f3w inkretynowych.<br data-start=\"3110\" data-end=\"3113\" \/><a class=\"decorated-link\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10107501\/\" target=\"_new\" rel=\"noopener\" data-start=\"3119\" data-end=\"3169\">https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10107501\/<\/a><\/p><\/li><li data-start=\"3171\" data-end=\"3414\"><p data-start=\"3174\" data-end=\"3414\"><strong data-start=\"3174\" data-end=\"3266\">Tirzepatide Once Weekly for the Treatment of Obesity \u2013 <em data-start=\"3231\" data-end=\"3264\">New England Journal of Medicine<\/em><\/strong> \u2013 dane z badania SURMOUNT-1 dotycz\u0105ce wp\u0142ywu tirzepatydu na mas\u0119 cia\u0142a w 72 tygodniach.<br data-start=\"3354\" data-end=\"3357\" \/><a class=\"decorated-link\" href=\"https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2206038\" target=\"_new\" rel=\"noopener\" data-start=\"3363\" data-end=\"3414\">https:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa2206038<\/a><\/p><\/li><li data-start=\"3416\" data-end=\"3631\"><p data-start=\"3419\" data-end=\"3631\"><strong data-start=\"3419\" data-end=\"3484\">Tirzepatide Once Weekly for the Treatment of Obesity (PubMed)<\/strong> \u2013 podsumowanie badania SURMOUNT-1 z PubMed, opis parametr\u00f3w metabolizmu i dzia\u0142a\u0144 niepo\u017c\u0105danych.<br data-start=\"3581\" data-end=\"3584\" \/><a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35658024\/\" target=\"_new\" rel=\"noopener\" data-start=\"3590\" data-end=\"3631\">https:\/\/pubmed.ncbi.nlm.nih.gov\/35658024\/<\/a><\/p><\/li><li data-start=\"3633\" data-end=\"3872\"><p data-start=\"3636\" data-end=\"3872\"><strong data-start=\"3636\" data-end=\"3724\">Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes \u2013 PubMed<\/strong> \u2013 wyniki badania SURPASS-2 por\u00f3wnuj\u0105cego tirzepatide z semaglutide w kontroli HbA1c i masy cia\u0142a.<br data-start=\"3822\" data-end=\"3825\" \/><a class=\"decorated-link\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34170647\/\" target=\"_new\" rel=\"noopener\" data-start=\"3831\" data-end=\"3872\">https:\/\/pubmed.ncbi.nlm.nih.gov\/34170647\/<\/a><\/p><\/li><li data-start=\"3874\" data-end=\"4075\"><p data-start=\"3877\" data-end=\"4075\"><strong data-start=\"3877\" data-end=\"3981\">ClinicalTrials.gov \u2013 A Study of Tirzepatide in Participants with Overweight and Obesity (SURMOUNT-1)<\/strong> \u2013 rejestr badania z protoko\u0142em i celami<br data-start=\"4022\" data-end=\"4025\" \/><a class=\"decorated-link\" href=\"https:\/\/clinicaltrials.gov\/study\/NCT04184622\" target=\"_new\" rel=\"noopener\" data-start=\"4031\" data-end=\"4075\">https:\/\/clinicaltrials.gov\/study\/NCT04184622<\/a><\/p><\/li><\/ol><hr data-start=\"3605\" data-end=\"3608\" \/><p><strong>Produkt przeznaczony do bada\u0144 naukowych i analizy laboratoryjnej. Wszystkie artyku\u0142y i informacje zamieszczone na tej stronie s\u0142u\u017c\u0105 wy\u0142\u0105cznie celom informacyjnym i edukacyjnym.<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p><strong data-start=\"140\" data-end=\"164\">Tirzepatide Pen 5 mg<\/strong> is an advanced synthetic peptide with dual activity against GIP and GLP-1 receptors, used in specialized studies of metabolic regulation and incretin signaling mechanisms.<\/p>","protected":false},"featured_media":30657,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[122,111,15],"product_tag":[],"class_list":{"0":"post-13022","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-produkty-w-penie","7":"product_cat-glp1gip","8":"product_cat-laboratory-research","10":"first","11":"outofstock","12":"shipping-taxable","13":"purchasable","14":"product-type-simple"},"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/product\/13022","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/comments?post=13022"}],"version-history":[{"count":33,"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/product\/13022\/revisions"}],"predecessor-version":[{"id":35468,"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/product\/13022\/revisions\/35468"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/media\/30657"}],"wp:attachment":[{"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/media?parent=13022"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/product_brand?post=13022"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/product_cat?post=13022"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/tirzepatyd.eu\/en\/wp-json\/wp\/v2\/product_tag?post=13022"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}